These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3068198)

  • 1. Acinetobacter calcoaceticus bacteremia 1984-1987.
    Yamashita J; Pien F; Collins RJ
    Hawaii Med J; 1988 Nov; 47(11):524-8. PubMed ID: 3068198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nosocomial bacteremia caused by Acinetobacter].
    Moreno S; Vicente T; Armas M; Bernaldo de Quirós JC; Rodríguez-Créixems M; Bouza E
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):606-9. PubMed ID: 2098118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical importance of bacteremias caused by Acinetobacter calcoaceticus].
    Gómez Garcés JL; Fernández Guerrero ML
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):622-5. PubMed ID: 2098121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of Acinetobacter spp septicemia in a neonatal ICU.
    Mittal N; Nair D; Gupta N; Rawat D; Kabra S; Kumar S; Prakash SK; Sharma VK
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):365-6. PubMed ID: 12971564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endemic nosocomial Acinetobacter calcoaceticus bacteremia. Clinical significance, treatment, and prognosis.
    Smego RA
    Arch Intern Med; 1985 Dec; 145(12):2174-9. PubMed ID: 4074029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter infection.
    Munoz-Price LS; Weinstein RA
    N Engl J Med; 2008 Mar; 358(12):1271-81. PubMed ID: 18354105
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mima polymorpha bacteremia].
    Golander A; Spirer Z; Bogair N; Konforti N
    Harefuah; 1973 Sep; 85(5):220-1. PubMed ID: 4755414
    [No Abstract]   [Full Text] [Related]  

  • 9. Ciprofloxacin in the treatment of nosocomial multiply resistant Acinetobacter calcoaceticus bacteremia.
    Leonov Y; Schlaeffer F; Karpuch J; Bourvin A; Shemesh Y; Lewinson G
    Infection; 1990; 18(4):234-6. PubMed ID: 2210856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital acquired native valve endocarditis caused by Acinetobacter calcoaceticus and treated with imipenem/cilastin.
    Cumberland NS; Jones KP
    J R Army Med Corps; 1987 Oct; 133(3):156-8. PubMed ID: 3479562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
    Hanlon GW
    Lett Appl Microbiol; 2005; 41(5):375-8. PubMed ID: 16238638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
    Kim YA; Choi JY; Kim CK; Kim CO; Kim MS; Choi SH; Chin BS; Han SH; Lee HS; Choi HK; Jeoung SJ; Song YG; Yum JH; Yong D; Lee K; Kim JM
    Scand J Infect Dis; 2008; 40(3):234-40. PubMed ID: 17852898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nosocomial pneumonia caused by multiresistant Acinetobacter baumanii treated by colistin and rifampicin].
    Motaouakkil S; Charra B; Hachimi A; Benslama A
    Ann Fr Anesth Reanim; 2006 May; 25(5):543-4. PubMed ID: 16488103
    [No Abstract]   [Full Text] [Related]  

  • 14. Acinetobacter bacteremia in Hong Kong: prospective study and review.
    Siau H; Yuen KY; Ho PL; Wong SS; Woo PC
    Clin Infect Dis; 1999 Jan; 28(1):26-30. PubMed ID: 10028065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia.
    Deris ZZ; Harun A; Shafei MN; Rahman RA; Johari MR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):140-7. PubMed ID: 19323046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the way of dealing with antibiotic exposure in studies assessing risk factors for drug-resistant pathogens.
    Prates CG; Zavascki AP
    Diagn Microbiol Infect Dis; 2009 May; 64(1):102; author reply 103. PubMed ID: 19232855
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of prognostic factors in 95 patients with Acinetobacter baumannii bacteremia.
    Chen CH; Lin LC; Chang YJ; Huang CC; Liu CE; Young TG
    Infection; 2003 Oct; 31(5):331-5. PubMed ID: 14556059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrug-resistant Acinetobacter baumannii calcoaceticus complex.
    Tacconelli E; Cataldo MA; De Pascale G; Manno D; Spanu T; Cambieri A; Antonelli M; Sanguinetti M; Fadda G; Cauda R
    J Antimicrob Chemother; 2008 Nov; 62(5):1130-7. PubMed ID: 18635519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acinetobacter sepsis in neonates.
    Shukla I; Siddiqui S; Ali SM
    Indian J Pathol Microbiol; 2006 Jan; 49(1):59-60. PubMed ID: 16625982
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
    Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.